Synexus Clinical Research Finance Limited
Synexus Clinical Research Finance Limited — dissolved UK company, incorporated 2007 (gb-coh:06408428). 1 holding, 15 officers. Every claim linked to its…
Registry identity
- Status
- dissolved
- Incorporated
- 2007-10-24
- Legal form
- ltd
- Activity
- 74909
- Registered office
- 12b Granta Park, Great Abington, Cambridge, CB21 6GB, England
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
None in current sources.
- Synexus Clinical Research Finance Limited
Nothing further is withheld here. The ownership and control links above are everything we have resolved for Synexus Clinical Research Finance Limited — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.
Coverage of Synexus Clinical Research Finance Limited is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.
Explore GB coverage4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
Nothing further on Synexus Clinical Research Finance Limited is behind a paywall — everything we hold on this subject is already on this page.
Register record, filings & financials
live · Companies House- Company no.
- 06408428
- Status
- dissolved
- Type
- ltd
- Incorporated
- 2007-10-24
- Registered office
- 12b Granta Park, Great Abington, Cambridge, CB21 6GB, England
- SIC
- 74909
People & control
14 parties · 3 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- HARRIS, Richard Stuart
- director · British · appointed 2021-12-29 · Companies House
- JAMES, Julia Mary
- director · British · appointed 2016-05-31 · Companies House
- Synexus Clinical Research Midco No 4 Limited
- corporate PSC · 75–100% shares · England · since 2016-04-06 · CH · PSC register
- BERTHOUX, Christophe
- director · French · appointed 2010-09-13 · resigned · Companies House
- CHAMBERS, Paul Michael
- director · British · appointed 2011-09-23 · resigned · Companies House
- FORT, Michael John
- director · British · appointed 2008-06-24 · resigned · Companies House
- HAND, Jeremy, Mr.
- director · British · appointed 2007-10-26 · resigned · Companies House
- HARLAND, David William Romanis
- secretary · British · appointed 2007-10-26 · resigned · Companies House
- director · British · appointed 2007-10-26 · resigned · Companies House
- HARTMAN, Brainard Judd
- director · American · appointed 2016-05-31 · resigned · Companies House
- MCCLUSKEY, Paul
- secretary · British · appointed 2008-06-25 · resigned · Companies House
- director · British · appointed 2008-06-25 · resigned · Companies House
- NEILD, Christopher David
- director · British · appointed 2016-05-31 · resigned · Companies House
- SYNEXUS CLINICAL RESEARCH ACQUISITIONS LIMITEDAlso holds roles at 2 other companies
- SYNEXUS CLINICAL RESEARCH LIMITEDbeneficial owner
- SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITEDbeneficial owner
- TRAVERS SMITH DIRECTORS LIMITED
- corporate director · appointed 2007-10-24 · resigned · Companies House
- TRAVERS SMITH SECRETARIES LIMITED
- corporate secretary · appointed 2007-10-24 · resigned · Companies House
- corporate director · appointed 2007-10-24 · resigned · Companies House
14 parties · 3 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Synexus Clinical Research Finance Limited?
- What is Synexus Clinical Research Finance Limited's risk level?
- Where does Synexus Clinical Research Finance Limited appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for Synexus Clinical Research Finance Limited — nothing is disclosed before that.